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Abstract
Background: We studied lateral inhibition in the somatosensory cortex of migraineurs during and between attacks, and
searched for correlations with thalamocortical activity and clinical features.
Participants and methods: Somatosensory evoked potentials (SSEP) were obtained by electrical stimulation of the
right median (M) or ulnar (U) nerves at the wrist or by simultaneous stimulation of both nerves (MU) in 41 migraine
without aura patients, 24 between (MO), 17 during attacks, and in 17 healthy volunteers (HVs). We determined the
percentage of lateral inhibition of the N20–P25 component by using the formula [(100)–MU/(MþU)*100]. We also
studied high-frequency oscillations (HFOs) reflecting thalamocortical activation.
Results: In migraine, both lateral inhibition (MO 27.9% vs HVs 40.2%; p¼ 0.009) and thalamocortical activity (MO 0.5 vs
HVs 0.7; p¼ 0.02) were reduced between attacks, but not during. In MO patients, the percentage of lateral inhibition
negatively correlated with days elapsed since the last migraine attack (r¼0.510, p¼ 0.01), monthly attack duration
(r¼0.469, p¼ 0.02) and severity (r¼0.443, p¼ 0.03), but positively with thalamocortical activity (r¼0.463,
p¼ 0.02).
Conclusions: We hypothesize that abnormal migraine cycle-dependent dynamics of connectivity between subcortical
and cortical excitation/inhibition networks may contribute to clinical features of MO and recurrence of attacks.
Keywords
Migraine, lateral inhibition, thalamocortical activity, clinical features, evoked potentials
Date received: 23 May 2015; revised: 25 July 2015; accepted: 9 August 2015
Background
The exact pathophysiological mechanisms underlying
the recurrence of migraine attacks are still not com-
pletely understood. Brainstem modulatory circuits
and altered cortical excitability may play a pivotal
role. In particular, clinical neurophysiology studies
have shown that in most migraine patients between
attacks cortical responsivity to various sensory stimuli,
except olfactory ones, is enhanced compared to con-
trols. This functional brain abnormality is not stable,
but cyclically changes up to the tipping point of the
attack when cortical responsivity normalizes (1).
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There is as yet no single causal explanation for this
dynamic cortical dysfunction and its precise role in
recurrence of migraine attacks and its possible relation
with clinical features of the disease are not known.
An imbalance between inhibitory and excitatory cor-
tical mechanisms, primary or secondary to reduced
cortical pre-activation levels because of an insufficient
thalamocortical drive, has been considered a possible
culprit (1).
That the cortical hyper-responsivity in migraine could
be due to abnormal thalamic control, and thus to so-
called ‘‘thalamocortical dysrhythmia’’ (TCD), is sug-
gested by studies of high-frequency oscillations (HFOs)
in spontaneous electroencephalogram (EEG) and evoked
potentials (2–4). This concept may reconcile the advocates
of excessive excitation or deficient inhibition, since a defi-
cient thalamocortical drive may result in a dysfunction of
both inhibitory and excitatory cortical neurons (5). In line
with the TCD hypothesis, we have recently shown that
short-range lateral inhibition is impaired interictally in the
visual cortex of migraine patients and that this impair-
ment contributes to the hyper-responsivity of visual-
evoked potentials (VEPs) found in migraine (6).
Among the various neurophysiological techniques,
somatosensory-evoked potentials (SSEPs) were sensi-
tive in disclosing abnormal cortical responsivity in
migraine patients studied interictally (4). They also
have the advantage of allowing reliable assessments of
HFOs as indices of thalamocortical activation (7).
In humans, simultaneous stimulations of a pair of
two adjacent peripheral nerves elicit smaller SSEPs
than separate stimulations of either of the two nerves.
Based on experimental models, mechanisms of lateral
inhibition are thought to account for SSEP suppression
after simultaneous dual input (8–10). To the best of our
knowledge, the degree of lateral inhibition in the som-
atosensory cortex has not been studied in episodic
migraine without aura (MO) nor its possible correlation
with thalamocortical activities.
Hence, we designed the present study to determine if
the degree of lateral inhibition in the somatosensory cortex
differs between MO patients recorded between or during
attacks and healthy volunteers (HVs). For this purpose,
we compared the amplitude of the low-frequency (LF)
SSEP components recorded over the parietal cortex after
stimulating simultaneously the median (M) and ulnar (U)
nerves with the arithmetic sum of the amplitudes of cor-
responding SSEP components elicited by stimulating each
nerve separately. Thereafter, we analyzed the HFOs
embedded in the SSEP obtained after median nerve stimu-
lation in terms of an early burst thought to be generated
by pre-synaptic thalamocortical afferents and a subsequent
component reflecting post-synaptic cortical activation.
We sought in particular whether there is a relation
between the degree of lateral inhibition and thalamocorti-
cal activity, or between electrophysiological patterns and
clinical features. We reasoned that, on the one hand, lat-
eral inhibition and thalamocortical activity would be
reduced between attacks, but normalized during an
attack, and that, on the other hand, these possible electro-




Among consecutive patients attending our headache
clinic, 41 patients (32 9 years old (y.o.); 28 women)
gave written informed consent to participate in the
study (Table 1), which was approved by the local
ethics committee.
All patients fulfilled International Classification of
Headache Disorders, third edition beta (ICHD-III
Table 1. Demographics and clinical features. Data expressed as mean SD.
HV (n¼ 17) MO (n¼ 24) MI (n¼ 17)
Women (n) 12 17 11
Age (years) 29 8 31 8 33 10
Duration of the migraine disease (years) 16.6 8.9 16.8 12.5
Attacks/month (n) 2.3 1.7 5.3 3.6a
Attacks duration (hours) 34.4 26.8 24.8 22.2
Days since the last migraine attack (n) 17.4 15.5
Severity of headache attacks (0–10) 7.6 1.7 7.2 1.6
Median nerve motor threshold (mA) 8.4 2.6 9.1 2.9 9.8 3.8
Ulnar nerve motor threshold (mA) 8.2 3.0 9.6 2.5 10.1 3.7
HV: healthy volunteers; MO: migraine without aura patients studied interictally (MO) or ictally (MI); N: number of
participants. (ap< 0.05 vs. MO).
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beta) diagnostic criteria for episodic migraine without
aura. Twenty-four patients (31 8 y.o.; 17 women)
were recorded during the interictal period (MO), i.e.
at least three days before and after an attack, 17
patients (33 10 y.o.; 11 women) during the ictal
period (MI), i.e. from 12 hours before to 12 hours
after an attack. The latter patients were not allowed
to take acute medications before the end of recordings.
We gathered information on various patient clinical
characteristics by collecting two-month headache dia-
ries at the time of either the screening visit and the day
of the recording session: duration of the migraine dis-
ease (years), attacks frequency (n/month), attacks dur-
ation (hours), severity of headache attacks (0–10), and
days elapsed from the last migraine attack (n) (Table 1).
For comparison, we recorded SSEPs in 17 HVs of
comparable age and sex distribution (29 8 y.o.; 12
women); they had no personal or familial history
(first- and second-degree relatives) of migraine and no
other detectable medical or psychiatric condition.
To avoid variability due to hormonal changes,
women were recorded outside their premenstrual or
menstrual periods.
Data acquisition
Three sets of SSEP recordings were performed in
random order at 5-minute intervals by two investiga-
tors (MB and DDL): M nerve stimulation, U nerve
stimulation and simultaneous stimulation of both
nerves (MU). The stimuli were constant current
square wave pulses (0.2ms width, cathode positioned
proximally), delivered at an intensity set at 1.2 times the
motor threshold and a repetition rate of 2.2Hz. The
first active electrode was placed over Erb’s point ipsilat-
eral to the stimulus referenced to the contralateral side;
the second and third recording electrodes were pos-
itioned over the fifth cervical spinous process (Cv5)
and over the contralateral parietal area (C30, 2 cm pos-
terior to C3 in the International 10–20 system), both
referenced to Fz; the ground electrode was on the right
arm. SSEP signals were amplified with a DigitimerTM
D360 pre-amplifier (Digitimer Ltd, UK) (band-pass
0.05–2500Hz, Gain 1000) and recorded with a
CEDTM power 1401 device (Cambridge Electronic
Design Ltd, Cambridge, UK).
During the recordings carried out in the afternoon
(between 2 p.m. and 6 p.m.), the participants sat relaxed
in a comfortable chair in a well-lit room with eyes open.
They were asked to fix attention on the stimulus-
induced thumb movement. For each of the three stimu-
lation protocols 300 consecutive sweeps of 50ms,
sampled at 5000Hz, were collected. All recordings
were analyzed off-line by one investigator (GC) blinded
to the participants’ diagnoses using the SignalTM
software package version 4.10 (CED Ltd). Artifacts
were automatically rejected using the SignalTM artifact
rejection tool if the signal amplitude exceeded 90% of
analog-to-digital converter (ADC) range and controlled
by visual inspection. The EP-signal was corrected off-
line for DC-drifts, eye movements and blinks.
LF-SSEPs and lateral inhibition
For each of the three stimulation protocols, 300 arti-
fact-free evoked responses were averaged in each indi-
vidual. After digital filtering of the signal between 0 and
450Hz, the various SSEP components (N9, N13, N20,
P25 and N33) were identified according to their laten-
cies. We measured peak-to-peak amplitudes of the per-
ipheral N9 (recorded under the active Erb’s point
electrode), the cervical N13 component (recorded
under the active Cv5 electrode), and the cortical N20
(from the preceding positive peak), N20–P25 (peak to
peak), and P25–N33 components (recorded under the
active C30 scalp electrode).
We calculated the percentage of lateral inhibition at the
successive relays of the somatosensory pathway using the
following formula: [100–(MU/(MþU)*100)], where MU
is the amplitude of the SSEP component obtained after
simultaneous stimulation of M and U nerves and MþU
the arithmetic sum of the amplitudes obtained by stimulat-
ing separately these nerves.
SSEP HFOs
Using a method described elsewhere (4), digital zero-
phase shift band-pass filtering between 450 and 750Hz
(Barlett-Hanning window, 51 filter coefficients) was
applied off-line on SSEPs elicited by M nerve alone
and by simultaneous stimulation of MU nerves in
order to extract the HFOs embedded in the parietal
N20 SSEP component. In the majority of recordings
we were able to identify two separate bursts of HFOs:
an early pre-synaptic burst within the latency interval
of the ascending slope of the conventional N20 SSEP
component and a late post-synaptic burst in the time
interval of the descending slope of N20, sometimes
extending into the ascending slope of the N33 peak.
In general, the frequency of the oscillations was
higher in the first than in the second burst and in
between the pre- and post-synaptic bursts there was a
clear frequency and amplitude decrease that allowed
the separation of the two bursts. In recordings in
which a clear distinction between the two components
was not possible, we considered HFOs occurring before
the N20 peak as pre-synaptic bursts and those after the
N20 peak as post-synaptic bursts.
After eliminating the stimulus artifact, we measured
the latency of the negative oscillatory maximum and
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the maximum peak-to-peak amplitude for each the two
HFO bursts, and separately for M and MU stimulus
conditions.
Statistical methods
We used the Statistical Package for the Social Sciences
(SPSS) for Windows, version 21.0 for all analyses. The
normal distribution of data for each group of individ-
uals was assessed with the Kolmogorov-Smirnov test.
A one-way analysis of variance (ANOVA) with group
factor ‘‘subjects’’ (episodic migraineurs without aura
studied ictally or interictally, and healthy participants)
was used. Tukey test was used for post hoc analyses.
Pearson’s correlation coefficient was used to search for
correlations between lateral inhibition and the median
nerve first HFO burst, as well as between SSEP
amplitudes or lateral inhibition and clinical data such
as severity of headache attacks (0–10), duration of
migraine history (years), monthly attack frequency
(n), attack duration (hours), and days elapsed since
the last migraine attack (n). P values less than 0.05
were considered to indicate statistical significance.
Results
The demographics of recorded participants and the
clinical characteristics of migraine patients are dis-
played in Table 1. This table also shows that there
was no difference in motor thresholds after M or U
nerve stimulation between the three groups of
participants.
Assessable SSEP recordings were obtained from all



































































Figure 1. (a) Illustrative traces of low-frequency somatosensory evoked potentials (LF-SSEPs) showing N9, N13 and N20–P25
components after stimulating the median (M) or the median and ulnar nerves simultaneously (MU), and the arithmetic sum of
responses obtained by stimulating each nerve separately (MþU) in a healthy volunteer (left traces), a migraine without aura patient
recorded interictally (middle traces) and during an attack (right traces). (b) Illustrative traces of pre- and post- synaptic high-frequency
oscillations obtained by digital band pass filtering (450–750 Hz) the median nerve SSEP responses in a healthy volunteer (HV), a
migraine without aura patient recorded interictally (MO) or during an attack (MI).
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LF-SSEPs and lateral inhibition
Amplitudes and latencies of SSEP components after
stimulation of M or U nerves were not different
between participant groups (Table 2).
Amplitudes of SSEP components after simultaneous
stimulation of MU nerves and the arithmetic sum of the
component amplitudes after separate stimulation of the
two nerves (MþU) also did not differ between groups
(Table 3).
ANOVA testing of the mean percentage of lateral
inhibition [100–((MU/MþU)*100)] for brachial plexus
N9, cervical spinal cord N13, and first cortical p-N20
components did not show a main effect for the factor
group (N9 component: F (2,55)¼ 0.344, p¼ 0.710; N13
component: F (2,55)¼ 0.329, p¼ 0.720; p-N20 compo-
nent: F (2,55)¼ 0.147, p¼ 0.862). By contrast, ANOVA
for the mean percentage of lateral inhibition [100–((MU/
MþU)*100)] of the cortical N20–P25 component dis-
closed a main effect for the factor group (F (2,55)¼
4.227, p¼ 0.019). Post hoc analysis revealed that the
lateral inhibition was significantly smaller in MO
patients (27.9% 17.1; p¼ 0.024) than in HVs (40.2%
 13.1), while in the MI group recorded during an attack
it was similar (37.3% 10.0) to HVs (Figure 2).
SSEP HFOs
After the stimulation of the M nerve alone, latency of
the negative oscillatory maximum of both pre- and
post-synaptic HFOs was not different between groups
(F (2,55)¼ 1.39, p¼ 0.26; F (2,55)¼ 0.69, p¼ 0.55,
respectively). Maximum peak-to-peak amplitude of
the pre-synaptic HFO burst, however, significantly
Table 2. Latencies and amplitudes of the various SSEP components after median or ulnar stimulation (mean standard deviation;
300 averaged responses).
HVs (n¼ 17) MO (n¼ 24) MI (n¼ 17)
Median Ulnar Median Ulnar Median Ulnar
N9 (ms) 10.1 0.8 10.6 1.1 10.1 0.8 10.4 0.8 9.7 0.8 10.3 0.9
N13 (ms) 13.4 1.3 14.1 1.5 13.4 1.1 13.8 1.2 13.3 1.2 14.1 1.5
N20 (ms) 19.1 1.2 19.6 1.0 18.8 1.0 20.0 1.6 18.9 1.1 19.6 1.3
P25 (ms) 24.1 2.5 24.6 2.4 22.7 1.8 24.0 2.2 24.0 2.2 23.9 2.3
N33 (ms) 30.8 2.9 31.2 2.7 29.9 3.0 30.6 2.6 31.1 2.3 32.4 2.9
N9-p (mV) 2.6 1.6 1.4 0.6 2.9 1.4 1.3 0.9 3.0 1.4 1.4 0.9
N13-p (mV) 1.7 0.7 0.9 0.5 1.7 0.6 1.1 0.6 1.8 0.7 1.2 0.4
p-N20 (mV) 0.9 0.5 0.6 0.4 0.8 0.5 0.6 0.4 1.2 0.6 0.7 0.4
N20–P25 (mV) 2.0 0.6 1.4 0.7 1.8 0.8 1.3 0.8 2.3 0.8 1.8 0.6
P25–N33 (mV) 0.7 0.3 0.7 0.5 1.0 0.6 0.8 0.5 0.9 0.5 1.1 0.5
There are no significant differences between groups.
HVs: healthy volunteers; MO: migraine without aura patients between attacks; MI: migraine patients during an attack; SSEP: somatosensory evoked
potentials.
Table 3. Amplitudes of the various SSEP components (mean standard deviation) after simultaneous median and ulnar nerve
stimulation (MU) or summed stimulation of these nerves (MþU) (300 averaged responses).
HVs (n¼ 17) MO (n¼ 24) MI (n¼ 17)
MU MþU MU MþU MU MþU
N9-p (mV) 1.8 1.0 3.7 1.9 2.7 1.8 4.3 2.1 3.2 1.3 4.4 1.6
N13-p (mV) 1.5 0.6 2.6 1.0 1.8 0.8 2.9 1.0 1.7 0.6 3.0 1.0
p-N20 (mV) 0.9 0.5 1.6 0.9 1.0 0.7 1.4 0.7 1.2 0.7 1.8 0.8
N20–P25 (mV) 2.1 0.9 3.4 1.2 2.2 1.0 3.2 1.5 2.5 0.9 4.0 1.3
P25–N33 (mV) 0.9 0.5 1.5 0.7 1.1 0.5 1.9 0.9 1.0 0.5 2.0 0.7
There are no significant differences between groups.
HVs: healthy volunteers; MO: migraine without aura patients between attacks; MI: migraine patients during an attack; SSEP: somatosensory evoked
potentials.
Coppola et al. 5
differed between groups (F (2,55)¼ 3.23, p¼ 0.04).
Post hoc analysis revealed that in MO patients the max-
imum peak-to-peak amplitude of the pre-synaptic HFO
burst was significantly lower than in HVs and MI
patients (Table 4). Maximum peak-to-peak amplitude
of the post-synaptic HFO burst did not differ between
groups (F (2,55)¼ 0.99, p¼ 0.38).
After the simultaneous stimulation of the MU
nerves, maximum peak-to-peak amplitudes and laten-
cies of the negative oscillatory maximum of pre- and
post- synaptic HFO were not different between groups
(Table 4).
Correlation analyses
Pearson’s test disclosed several correlations between
neurophysiological and clinical variables. Between
attacks, Pearson’s test disclosed a negative correlation
between N20–P25 SSEP amplitudes after separate
stimulation of the M or U nerves (M: r¼0.442,
p¼ 0.04; U: r¼0.597, p¼ 0.004) or their arithmetic
sum (MþU: r¼0.529, p¼ 0.01) and days elapsed at
the time of recordings since the last migraine attack
(Figure 3). The percentage of lateral inhibition for the



































Figure 2. Histogram showing the mean percentage of lateral inhibition (100–((MU/MþU)*100) for the N20–P25 component in
healthy volunteers (HVs) and in migraineurs recorded interictally (MO) or ictally (MI). M: median; U: ulnar.
Table 4. Latencies and maximal amplitudes (mean standard deviation) of the first (pre-synaptic) and second (post-synaptic) HFOs
embedded in median nerve SSEPs after stimulation of median (M) nerve alone and after simultaneous stimulation of the median and
ulnar (MU) nerves.
HVs (n¼ 17) MO (n¼ 24) MI (n¼ 17)
Pre-synaptic Post-synaptic Pre-synaptic Post-synaptic Pre-synaptic Post-synaptic
M
Latency of maximum negative peak (ms) 15.7 1.4 22.3 2.0 16.3 0.8 22.0 1.7 16.0 1.3 22.7 2.2
Maximum peak-to-peak amplitude (mV) 0.07 0.03 0.08 0.02 0.05 0.02a 0.08 0.04 0.06 0.02 0.06 0.04
MU
Latency of maximum negative peak (ms) 16.1 0.5 22.6 1.4 16.2 0.5 22.9 1.9 16.0 0.8 22.7 1.3
Maximum peak-to-peak amplitude (mV) 0.04 0.02 0.04 0.02 0.06 0.03 0.07 0.05 0.06 0.05 0.05 0.04
M: Pre-synaptic HFO amplitude is significantly smaller in MO compared to HV (aANOVA p< 0.05).
There are no significant between group differences for post-synaptic HFOs.
MU: There are no significant between stimulus condition differences for pre- and post-synaptic HFOs in both MO and MI patients groups.
HFOs: high-frequency oscillations; HVs: healthy volunteers; MO: migraine without aura patients between attacks; MI: migraine patients during an attack;
SSEP: somatosensory evoked potentials; ANOVA: analysis of variance.
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also correlated negatively with days from the last
migraine attack (r¼0.510, p¼ 0.01, Figure 3),
mean attack duration (r¼0.469, p¼ 0.02) and sever-
ity of migraine attacks (r¼0.443, p¼ 0.03, Figure 4),
but it correlated positively with pre-synaptic M HFOs
(r¼ 0.463, p¼ 0.02, Figure 5). Amplitude of pre-
synaptic HFOs was negatively correlated with mean
attack duration (r¼0.485, p¼ 0.01, Figure 5).
There was no significant correlation between neuro-
physiological and clinical data in MI patients recorded
during an attack.
Discussion
Our study confirms previous findings showing that amp-
litude of pre-synaptic HFOs embedded in somatosensory
4.5
[M]
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Figure 3. Correlation between the number of days elapsed since the last migraine attack and N20–P25 low-frequency somato-
sensory evoked potentials (LF-SSEP) amplitude (component N20–P25) after stimulating the median (M) or the ulnar (U) nerve
separately, the arithmetic sum of median and ulnar nerve responses (MþU), and the mean percentage of lateral inhibition (100–((MU/
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Figure 4. Correlation between the mean percentage of lateral inhibition (100–((MU/MþU)*100) for the N20–P25 low-frequency
somatosensory evoked potentials (LF-SSEP) component and severity of headache attacks (a), as measured by a visual analog scale
(VAS), and mean attack duration (b) in migraine patients between attacks. M: median; U: ulnar.
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evoked responses is reduced in episodic migraine between
attacks, which is suggestive of diminished thalamocorti-
cal activity. By contrast, amplitudes of post-synaptic
HFOs and of grand-average LF-SSEP components are
within normal limits (4,11). An additional novel finding
for SSEPs is that amplitude of the cortical N20–P25 com-
ponent for all three stimulation paradigms is negatively
correlated with time elapsed between the last migraine
attack and the recordings, suggesting that amplitude of
cortical SSEPs fluctuates with the migraine cycle, being
minimal between attacks but increasing in proximity of
or during an attack.
However, the most original aspect of our study is to
show that lateral inhibition in the somatosensory cortex
is reduced in MO patients between attacks, but normal
during an attack. Moreover, we find that the degree of
lateral inhibition is directly related with somatosensory
thalamocortical activity, as indexed by amplitude of
pre-synaptic HFOs, and inversely related to days
elapsed since the last attack, severity of the migraine
headache and attack duration. This suggests that
reduced lateral inhibition in migraine is a consequence
of poor thalamocortical drive, but also a marker of
migraine severity.
Next to LF cortical SSEP representing the temporal
marker of post-synaptic primary sensory cortex (S1)
activation (12) and HFOs of SSEP reflecting thalamo-
cortical fiber activity and primary cortical activation (7)
it is possible to study lateral surrounding inhibition
between neurons of the somatosensory cortex by stimu-
lating adjacent nerves and the interaction between the
afferent volleys produced by such simultaneous stimu-
lation. It was shown indeed that in a subpopulation of
neurones adequately activated by two different afferent
inputs, the potentials recorded after simultaneous
stimulation of two adjacent nerves are less ample than
the arithmetic sum of the potentials generated by each
stimulation separately (13,14). When converging inputs
produce a response that is greater than the sum of the
responses to each input in isolation, this is interpreted
as due to lack of lateral inhibitory mechanisms (8).
There is ample experimental evidence from electro-
physiological single-unit recordings in animals that
paired stimulations of the adjacent finger result in
response suppression relative to single-digit stimula-
tion, suggesting the presence of lateral inhibition
across columns in layers two-thirds of area 3 b (9,10).
Although SSEPs in supragranular layers are generated
mainly by glutamate-mediated depolarization (15), they
are under the inhibitory control of non-pyramidal
GABAergic neurons (16). Among them, those with
the largest lateral axonal field (>700 mm) are the puta-
tive neuronal mediators of short-range lateral inhib-
ition between cortical columns (10). Given these data
on the anatomo-physiological organization of the som-
atosensory cortex, our findings suggest that in migraine
there is a cycle-dependent abnormal dynamic of the
excitatory-inhibitory balance in response to peripheral
somatosensory stimulation.
The various psychophysical and electrophysiological
studies that have explored the central balance between
inhibition and excitation in migraine are in line with
this interpretation. In a pattern adaptation paradigm
using visual illusions, a phenomenon attributed to a
decrease in excitation from tonic pre-synaptic inputs,
tilt after-effects, motion after-effects (17) and simultan-
eous tilt illusion (18) are prolonged in migraineurs as
compared to HVs. This slow adaptation speed in
migraine was attributed to a disequilibrium between
excitatory and inhibitory mechanisms in the visual
cortex (17–20). In a recent steady-state VEP study in
which about 200 stimuli were delivered, supersaturation
of VEP contrast gain was found in migraine between
attacks and considered as supportive of excessive exci-
tation driving increased network inhibition (21). When
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Figure 5. Correlation between amplitude maximum of pre-synaptic high-frequency somatosensory evoked potentials (SSEP)
oscillations (HFOs), reflecting thalamocortical activity and the percentage of lateral inhibition (100–((MU/MþU)*100) for the
N20–P25 low-frequency LF-SSEP component (left), or mean attack duration (right) in migraine patients between attacks. M: median;
U: ulnar.
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of response is different. In a refined steady-state VEP
protocol using a windmill-dartboard (W-D) pattern of
600 stimuli, thought to explore preferentially short-
range lateral inhibition, we have found a dual cortical
response pattern: Lateral inhibition initially increases,
in line with the VEP evidence mentioned above, while it
decreases during the continuous stimulus repetition in
MO but not in HVs (6). This observation is relevant to
the present study that shows deficient lateral inhibitory
mechanisms in the somatosensory cortex by analyzing
grand-average SSEP between attacks after long-term
stimulation, i.e. a condition quite similar to the final
response pattern of W-D VEPs.
Another distinctive finding in our study is that the
degree of lateral inhibition in the somatosensory cortex
fluctuates over time in relation to the occurrence of a
migraine attack: It is minimal at a long time interval
after an attack while it is greater and within the range
of normative values during an attack, which parallels
the temporal dynamics of the LF-SSEP N20–P25 amp-
litude. The dynamic SSEP variations found here resem-
ble those we have previously reported for VEPs after
long-term stimulation, i.e. an interictal decrease as
opposed to an ictal increase of lateral inhibition (6).
In addition, a comparable correlation with the
number of days elapsed between the last attack and
the recordings was found in migraine for short-range
lateral inhibition in the visual cortex (6), but also for
visual metacontrast masking (22), functional magnetic
resonance imaging (fMRI) blood oxygenation level-
dependent (BOLD) response in the spinal trigeminal
nuclei after intranasal nociceptive stimulation (23) or
fractional anisotropy values in the thalamus (24). The
latter is of particular interest for our finding of a strong
positive correlation between thalamocortical activity
and degree of lateral inhibition in MO patients: The
lower the thalamocortical activity, the lesser the lateral
inhibition. Globally, these results indicate that the over-
all subcortico/cortical drive changes with proximity of
the last migraine attack.
A simultaneous dysfunction of thalamocortical
activity and of cortical lateral inhibition is the hallmark
of various functional brain disorders grouped under the
name ‘‘thalamocortical dysrhythmia’’ (TCD) syn-
dromes. The TCD theory proposes that a functional
and anatomical disconnection of the thalamus from
subcortical areas induces a change of rhythmic thala-
mocortical activity favoring cortical rhythms of lower
frequency. This will reduce excitation of pyramidal cells
at the beginning of the stimulus and of fast-spiking (FS)
inhibitory interneurons during stimulus repetition (25).
Converging evidence of abnormal thalamic/thalamo-
cortical activity in migraine between attacks comes
from the analysis of spontaneous (2) and evoked (3,4)
rhythmic brain activity as well as from functional
(26,27) and structural (24,28) neuroimaging studies.
We have therefore hypothesized that migraine might
belong to the thalamocortical dysrhythmias and that,
in line with the TCD theory, low activity of the mono-
aminergic input to the thalamus and cortex might cause
a functional disconnection of the thalamus leading to
increased gamma band oscillations in the cortex and to
reduced lateral inhibition (3).
Biochemical (29) and neuroimaging (30) studies
indicate that in migraine monoaminergic transmission
is altered. The brainstem aminergic nuclei modulate
both the endogenous antinociceptive system and cen-
tral processing of sensory stimuli by controlling pre-
activation levels and signal-to-noise ratio in cortical
and thalamocortical neurons (31). As a matter of
fact, the subcortical pain control systems seem to be
hypoactive in migraine between attacks (32–34), while
they may be hyperactive during the headache phase
(35). An interictal dysfunction of the brainstem pain
could thus perturb central sensory processing, and
hence cortical metabolic homeostasis, and at the
same time disinhibit the pain-signaling trigeminovascu-
lar system, hence paving the way for a migraine attack.
Indirect evidence in favor of this hypothesis comes
from our finding that the degree of lateral inhibition
in the somatosensory cortex is inversely correlated
with clinical features of migraine attacks reflecting its
severity, such as intensity and duration of the head-
ache (see Figure 4). The latter was also negatively
related to thalamocortical activity, as assessed by amp-
litude of pre-synaptic HFOs, i.e. the greater the deficit
of thalamocortical activation, the longer-lasting the
headache attacks. That a worse clinical manifestation
of migraine may be associated with low thalamocorti-
cal drive activity is also supported by the previous
observation that patients who experience an increase
in the number of migraine attacks during the six
months following the recording session thalamocorti-
cal drives are reduced with respect to those who
showed an improvement of migraine state (36).
Finally, we acknowledge as a limitation of the pre-
sent study that not all the patients in the two groups
(MO/MI) served as their own baseline reference,
making impossible an immediate generalizability of
our findings. Following the same patients longitudin-
ally would have provided more robust statistical power.
However, this point should not be considered detrimen-
tal because the two groups of patients (MO/MI) were
recorded regardless during clearly distinctive periods
during the so-called migraine cycle.
Conclusions
In conclusion, we have shown that lateral inhibitory
mechanisms are impaired between attacks in the
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somatosensory cortex of migraine patients. We found
that this impairment decreases in proximity to an
attack, that it is associated with decreased thalamocor-
tical activity and that it is directly correlated with the
intensity and duration of usual migraine attacks. We
propose that these data suggest that the aminergic
brainstem-modulating systems are hypofunctioning
between attacks and thus, either directly or indirectly
via the thalamocortical loops, perturb both cortical
information processing and endogenous pain control
predisposing the migraineur to a migraine attack.
Future work should attempt to clarify the role of the
somatosensory lateral inhibition mechanisms with
regard to habituation/sensitization phenomena in epi-
sodic and chronic migraine.
Clinical implications
. Mechanisms of lateral inhibitory are impaired between attacks in the somatosensory cortex of migraine
patients.
. This impairment decreases in proximity to an attack, is associated with low thalamocortical activity and is
directly correlated with the intensity and duration of usual migraine attacks.
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